Page 232 - Read Online
P. 232

Singh et al.                                                                                                                                                         Myocardial protection in cardiac transplantation

           by RIC at cross-clamp times of 57-75 min (ratio of RIC/  Table design: S. Das De
           control = 0.757; P = 0.0348) and of ≥ 76 min (ratio of   Reviewing, editing, supervision: C. Spadaccio, C.
           RIC/control = 0.735; P = 0.0277) [146] . RIC theoretically   Berry, N. Al-Attar
           confers protection against ischaemia but not trauma
           during surgery (cannulation/handling); thus making   Financial support and sponsorship
           it plausible that in longer cross-clamp times, the   None.
           protection conferred by RIC becomes more overt due
           to the effect of ischaemic/reperfusion injury. Another   Conflicts of interest
           recent study what studied the effect of preconditioning   There are no conflicts of interest.
           with cyclosporine-A  (which prevents  MPTP  opening
           at the onset of reperfusion, thereby also reducing   Patient consent
           the incidence of ischaemic-reperfusion injury [147]  in   Not applicable.
           patients  undergoing  elective  CABG  revealed  similar
           findings,  with  the  cardioprotective  benefits  noted  at   Ethics approval
           longer cross-clamp times (85-120 min) but not in the   Not applicable.
           shorter (50-85 min) group [148] .
                                                              REFERENCES
           Iyer  et  al. [149]   utilised PostC in DCD hearts  using a
           porcine asphyxia model and subjected them to warm   1   Ravishankar V. March of cardiac surgery through the decades. Med J
           ischaemic  times  of  20-40  min  prior  to  flushing  with   2.   Armed Forces India 2014;70:3-4.
                                                                 Konstantinov IE. At the cutting edge of the impossible: a tribute to
           Celsior  solution.  The  solution  was  supplemented   Vladimir P. Demikhov. Tex Heart Inst J 2009;36:453-8.
           with erythropoietin [150] ,  glyceryl trinitrate [151,152]  and   3.   Lower RR, Stofer RC, Hurley EJ, Dong E Jr, Cohn RB, Shumway
           zoniporide  (Cs) [153] ,  a  combination that  activates   NE. Successful homotransplantation of the canine heart after anoxic
           ischaemic postconditioning pathways.                  preservation for seven hours. Am J Surg 1962;104:302-6.
                                                              4.   Dong E Jr, Hurley EJ, Lower RR, Shumway NE. Performance of the
           Hearts  were  assessed  for  functional,  biochemical  and   heart two years after autotransplantation. Surgery 1964;56:270-4.
           metabolic recovery on an ex-vivo working heart apparatus.   5.   Shumway NE, Lower RR. Special problems in transplantation of the
                                                                 heart. Ann N Y Acad Sci 1964;120:773-7.
           Hearts  with  postconditioning  pathways  activated   6.   Barnard CN. The operation. A human cardiac transplant: an interim
           demonstrated complete recovery up to 20-min of warm   report of a successful operation performed at Groote Schuur Hospital,
           ischaemia time after which a rapid decline ensued.    Cape Town. S Afr Med J 1967;41:1271-4.
                                                              7.   Lansman SL, Ergin MA, Griepp RB. The history of heart and heart-
           CONCLUSION                                            lung transplantation. Cardiovasc Clin 1990;20:3-19.
                                                              8.   Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk
                                                                 R, Dobbels F, Rahmel AO, Hertz MI. The registry of the international
           There have been multiple recent advances in recent    society for heart and lung transplantation: twenty-seventh official adult
           times with specific interest in myocardial protection. The   heart transplant report--2010. J Heart Lung Transplant 2010;29:1089-
           search for biomarkers however continue to persist and   103.
           may  provide  a  gauge  to  quantify  myocardial  damage.   9.   Lietz K, Miller LW. Improved survival of patients with end-stage heart
           Continuous  normothermic organ perfusion  remains  an   failure listed for heart transplantation: analysis of organ procurement
                                                                 and transplantation network/U.S. United Network of Organ Sharing
           interesting prospect that allows transport and working   data, 1990 to 2005. J Am Coll Cardiol 2007;50:1282-90.
           assessment  of  the  heart  prior  to  transplantation.  This   10.  Abuanzeh R, Hashmi F, Dimarakis I, Khasati N, Machaal A, Yonan
           has revolutionised DCD transplantation thus added     N, Venkateswaran  RV. Early  donor  management  increases  the
           more organs to the potential donor pool. Short term   retrieval rate of hearts for transplantation in marginal donors. Eur J
           outcomes of DCD hearts have been good, however long-  Cardiothorac Surg 2015;47:72-7; discussion 77.
           term outcomes need to be studied to allow widespread   11.  Ringer  S.  A  further  contribution  regarding  the  influence  of  the
           use. The role of ischaemic pre- and post-conditioning   different constituents of the blood on the contraction of the heart. J
                                                                 Physiol 1883;4:29-42.
           remain uncertain in the field of cardiac transplantation.   12.  Tyers GF,  Todd GJ,  Niebauer IM,  Manley NJ,  Waldhausen JA..
           A summation of myocardial protection strategies may be   The mechanism of myocardial  damage following potassium citrate
           the way forward.                                      (Melrose) cardioplegia. Surgery 1975;78:45-53.
                                                              13.  Maathuis MH, Leuvenink  HG, Ploeg RJ. Perspectives  in organ
           DECLARATIONS                                          preservation. Transplantation 2007;83:1289-98.
                                                              14.  tHart  NA, Leuvenink  HGD, Ploeg  RJ. New solutions  in  organ
                                                                 preservation. Available from: http://www.sciencedirect.com/science/
           Authors’ contributions                                article/pii/S0955470X02800027. [Last accessed on 20 Oct 2017]
           Writing: S.S.A. Singh                              15.  Shumway NE, Lower RR. Topical cardiac hypothermia for extended
           Conceptualisation: N. Al-Attar                        periods of anoxic arrest. Surg Forum 1960;10:563-6.

                           Vessel Plus ¦ Volume 1 ¦ December 28, 2017                                     225
   227   228   229   230   231   232   233   234   235   236   237